Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Bylund

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|October 25, 2007
Alpha- and beta-adrenergic receptors: Ahlquist's landmark hypothesis of a single mediator with two receptorsDavid B Bylund
British Journal of Pharmacology|January 19, 2005
Alpha-2 adrenoceptor subtypes: are more better?David B Bylund
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 31, 2007
Selecting selectivities and the neuropharmacology of antidepressant drug action: a commentaryDavid B Bylund
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2011
Radioligand binding methods for membrane preparations and intact cellsDavid B Bylund, Myron L Toews
Neurochemistry International|August 1, 2007
Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?David B Bylund, Abbey L Reed
Proceedings of the American Thoracic Society|November 4, 2005
Pharmacologic principles for combination therapyMyron L Toews, David B Bylund
Biochemical Pharmacology|August 13, 2013
Quantitative versus qualitative data: the numerical dimensions of drug actionDavid B Bylund, Myron L Toews
Advances in Pharmacology (San Diego, Calif.)|February 8, 2018
Receptor Binding Assays and Drug DiscoveryDavid B Bylund, S J Enna
Neuropharmacology|December 1, 2007
The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatmentMegan E Kozisek, David Middlemas, David B Bylund
Pharmacology & Therapeutics|October 24, 2007
Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapiesMegan E Kozisek, David Middlemas, David B Bylund
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
American Journal of Physiology. Endocrinology and Metabolism|October 25, 2007
Alpha- and beta-adrenergic receptors: Ahlquist's landmark hypothesis of a single mediator with two receptorsDavid B Bylund
British Journal of Pharmacology|January 19, 2005
Alpha-2 adrenoceptor subtypes: are more better?David B Bylund
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 31, 2007
Selecting selectivities and the neuropharmacology of antidepressant drug action: a commentaryDavid B Bylund
Methods in Molecular Biology (Clifton, N.J.)|May 25, 2011
Radioligand binding methods for membrane preparations and intact cellsDavid B Bylund, Myron L Toews
Neurochemistry International|August 1, 2007
Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs?David B Bylund, Abbey L Reed
Proceedings of the American Thoracic Society|November 4, 2005
Pharmacologic principles for combination therapyMyron L Toews, David B Bylund
Biochemical Pharmacology|August 13, 2013
Quantitative versus qualitative data: the numerical dimensions of drug actionDavid B Bylund, Myron L Toews
Advances in Pharmacology (San Diego, Calif.)|February 8, 2018
Receptor Binding Assays and Drug DiscoveryDavid B Bylund, S J Enna
Neuropharmacology|December 1, 2007
The differential regulation of BDNF and TrkB levels in juvenile rats after four days of escitalopram and desipramine treatmentMegan E Kozisek, David Middlemas, David B Bylund
Pharmacology & Therapeutics|October 24, 2007
Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapiesMegan E Kozisek, David Middlemas, David B Bylund
Pageof 3